Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

M. Moehler, J. Heo, H.C. Lee, W.Y. Tak, Y. Chao, S.W. Paik, H.J. Yim, K.S. Byun, A. Baron, G. Ungerechts, D. Jonker, L. Ruo, M. Cho, A. Kaubisch, H. Wege, P. Merle, O. Ebert, F. Habersetzer, J.F. Blanc, Olivier Rosmorduc, R. Lencioni, R. Patt, A.M. Leen, F. Foerster, M. Homerin, N. Stojkowitz, M. Lusky, J.M. Limacher, M. Hennequi, N. Gaspar, B. McFadden, N. De Silva, D. Shen, A. Pelusio, D.H. Kirn, C.J. Breitbach, J.M. Burke

Open source

DOI: 10.1080/2162402x.2019.1615817
Published: 2019-06-03
Container: OncoImmunology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2019.1615817,
  title = {Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)},
  author = {M. Moehler and J. Heo and H.C. Lee and W.Y. Tak and Y. Chao and S.W. Paik and H.J. Yim and K.S. Byun and A. Baron and G. Ungerechts and D. Jonker and L. Ruo and M. Cho and A. Kaubisch and H. Wege and P. Merle and O. Ebert and F. Habersetzer and J.F. Blanc and Olivier Rosmorduc and R. Lencioni and R. Patt and A.M. Leen and F. Foerster and M. Homerin and N. Stojkowitz and M. Lusky and J.M. Limacher and M. Hennequi and N. Gaspar and B. McFadden and N. De Silva and D. Shen and A. Pelusio and D.H. Kirn and C.J. Breitbach and J.M. Burke},
  year = {2019},
  journal = {OncoImmunology},
  doi = {10.1080/2162402x.2019.1615817},
  url = {https://doi.org/10.1080/2162402x.2019.1615817}
}

RIS

TY  - JOUR
TI  - Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
AU  - M. Moehler
AU  - J. Heo
AU  - H.C. Lee
AU  - W.Y. Tak
AU  - Y. Chao
AU  - S.W. Paik
AU  - H.J. Yim
AU  - K.S. Byun
AU  - A. Baron
AU  - G. Ungerechts
AU  - D. Jonker
AU  - L. Ruo
AU  - M. Cho
AU  - A. Kaubisch
AU  - H. Wege
AU  - P. Merle
AU  - O. Ebert
AU  - F. Habersetzer
AU  - J.F. Blanc
AU  - Olivier Rosmorduc
AU  - R. Lencioni
AU  - R. Patt
AU  - A.M. Leen
AU  - F. Foerster
AU  - M. Homerin
AU  - N. Stojkowitz
AU  - M. Lusky
AU  - J.M. Limacher
AU  - M. Hennequi
AU  - N. Gaspar
AU  - B. McFadden
AU  - N. De Silva
AU  - D. Shen
AU  - A. Pelusio
AU  - D.H. Kirn
AU  - C.J. Breitbach
AU  - J.M. Burke
PY  - 2019
JO  - OncoImmunology
DO  - 10.1080/2162402x.2019.1615817
UR  - https://doi.org/10.1080/2162402x.2019.1615817
ER  -

APA

Moehler, M., Heo, J., Lee, H., Tak, W., Chao, Y., Paik, S., Yim, H., Byun, K., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Habersetzer, F., Blanc, J., Rosmorduc, O., Lencioni, R., Patt, R., Leen, A., Foerster, F., Homerin, M., Stojkowitz, N., Lusky, M., Limacher, J., Hennequi, M., Gaspar, N., McFadden, B., Silva, N. D., Shen, D., Pelusio, A., Kirn, D., Breitbach, C., & Burke, J. (2019). Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE). OncoImmunology. https://doi.org/10.1080/2162402x.2019.1615817

Source records

crossref · retrieved 2026-09-25T19:32:13.375Z